Ivanciuc Ovidiu, Midoro-Horiuti Terumi, Schein Catherine H, Xie Liping, Hillman Gilbert R, Goldblum Randall M, Braun Werner
Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0857, United States.
Mol Immunol. 2009 Feb;46(5):873-83. doi: 10.1016/j.molimm.2008.09.004. Epub 2008 Oct 23.
Similarities in the sequence and structure of allergens can explain clinically observed cross-reactivities. Distinguishing sequences that bind IgE in patient sera can be used to identify potentially allergenic protein sequences and aid in the design of hypo-allergenic proteins. The property distance index PD, incorporated in our Structural Database of Allergenic Proteins (SDAP, http://fermi.utmb.edu/SDAP/), may identify potentially cross-reactive segments of proteins, based on their similarity to known IgE epitopes. We sought to obtain experimental validation of the PD index as a quantitative predictor of IgE cross-reactivity, by designing peptide variants with predetermined PD scores relative to three linear IgE epitopes of Jun a 1, the dominant allergen from mountain cedar pollen. For each of the three epitopes, 60 peptides were designed with increasing PD values (decreasing physicochemical similarity) to the starting sequence. The peptides synthesized on a derivatized cellulose membrane were probed with sera from patients who were allergic to Jun a 1, and the experimental data were interpreted with a PD classification method. Peptides with low PD values relative to a given epitope were more likely to bind IgE from the sera than were those with PD values larger than 6. Control sequences, with PD values between 18 and 20 to all the three epitopes, did not bind patient IgE, thus validating our procedure for identifying negative control peptides. The PD index is a statistically validated method to detect discrete regions of proteins that have a high probability of cross-reacting with IgE from allergic patients.
过敏原在序列和结构上的相似性可以解释临床上观察到的交叉反应性。区分患者血清中与IgE结合的序列可用于识别潜在的变应原性蛋白序列,并有助于低变应原性蛋白的设计。我们的变应原性蛋白质结构数据库(SDAP,http://fermi.utmb.edu/SDAP/)中纳入的特性距离指数PD,可以根据蛋白质与已知IgE表位的相似性,识别蛋白质中潜在的交叉反应片段。我们试图通过设计相对于山地雪松花粉主要变应原Jun a 1的三个线性IgE表位具有预定PD分数的肽变体,来获得PD指数作为IgE交叉反应性定量预测指标的实验验证。对于这三个表位中的每一个,设计了60个与起始序列相比PD值增加(物理化学相似性降低)的肽。用对Jun a 1过敏患者的血清检测在衍生化纤维素膜上合成的肽,并采用PD分类方法解释实验数据。相对于给定表位PD值低的肽比PD值大于6的肽更有可能结合血清中的IgE。与所有三个表位的PD值在18至20之间的对照序列不结合患者IgE,从而验证了我们识别阴性对照肽的程序。PD指数是一种经过统计学验证的方法,用于检测蛋白质中与过敏患者的IgE发生交叉反应可能性很高的离散区域。